ArticleCancer medicine2017

The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.

Daisuke Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.